Challenges in bone surgery
Bone cutting procedures have risks of complications, which are caused by surgical drill cutting or damaging soft structures, such as central nervous system structures. For example, there is up to 30% risk of damaging soft tissues in skull opening procedures. Reducing these complications rates by making the drill more controllable and safer for soft tissues is preferred.
The benefits of Surgify technology
Safety
Surgify technology enables surgeons to reduce patient suffering by protecting the vital structures, such as nerves, blood vessels and organs.
Speed
Faster operations means less risks for the patient by decreasing the required anesthesia time and the risk of complications. It also allows hospitals to treat more patients with lower costs.
Precision
Surgify technology provides superior precision compared to conventional cutting tools, allowing surgeons to operate in hard to reach areas.
This will be a breakthrough!
Professor Emeritus Juha Hernesniemi
Neurosurgery, University of Helsinki
In elderly patients the intracranial dura, often tightly attached to the overlaying skull bone, requires meticulous dissection not to be torn during craniotomy.
Professor Juha E Jääskeläinen
Chairman of Neurosurgery, NeuroCenter, Kuopio University Hospital
There are many ways to fix dural tears, but preventing those would be much more helpful, efficient and cost saving, and of course helps the patient recover.
Professor Emeritus John Koivukangas
Neurosurgeon, Oulu University Hospital
I see a lot of promise in Surgify!
Professor Mika Niemelä
Head of Neurosurgery, Helsinki University Central Hospital
Team with multidisciplinary expertise
Visa Sippola
is the CEO and Co-Founder of Surgify and responsible for making our product meet the customer needs. Before initiating this project, he was working as a researcher at Helsinki and Uusimaa Hospital District.
Shahab Haeri
is the CTO and Co-Founder of Surgify, who has the skills to make our solution a reality. He has been fully involved in Surgify since the beginning of the project.
Juho Carpén
is the CFO and Co-Founder of Surgify and responsible for making Surgify a viable and profitable business. Before joining the team in its early phase, he has been involved in multiple strategy and market analysis projects.
Jukka Kreander
is the CQO and Co-Founder of Surgify, who is responsible for development of quality management systems and regulatory affairs. He has gained experience from life science companies, such as GE Healthcare, Sooma, and MDS Finland.
Junaid Akhtar
is an engineering design manager, who is closely involved in the technology development. His product development and engineering skills are highly valuable for Surgify.
Bijan Bayat Mokhtari
is a manufacturing manager, who has responsibilities in agile prototyping, testing, and the development of the Surgify Safety Burr.
Photos: villetikkanen.com
Extensive network of advisors
Professor Emeritus Juha Hernesniemi
Neurosurgery, University of Helsinki
Professor Mika Niemelä
Head of Neurosurgery, Helsinki University Central Hospital
Jari Salo
Professor of Orthopedics & Traumatology, Chairman of Mehiläinen Töölö hospital
Matti Seppälä
Neurosurgeon, Helsinki University Central Hospital
Tarja Pääkkönen
Veterinary Neurologist, University of Helsinki
Petri Kuosmanen
Professor of Machine Design, Aalto University
Jani Virtanen
Co-founder at Sooma Oy
Company background
The core team of Surgify has worked on developing solutions for safer bone surgery since the beginning of 2015. With initial proof-of-concept and market studies, the Surgify team applied successfully for a governmental research grant from Business Finland and Aalto University to prepare the commercialization of a new bone cutting technology in January 2016.
During the university commercialization project, the Surgify team developed and successfully tested a technology, which is capable of protecting soft structures during bone surgery and preventing the associated complications. We have been working in close cooperation with Neurosurgical Department of Helsinki University Central Hospital, in order to ensure that the technology always fulfils the expectations of a clinician. Currently, the Surgify team is committed to finalize and commercialize the technology with the goal of making safer bone surgery accessible to all of us.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 878204.
Butterfly Ventures
- Investor
Cascara Ventures
- Investor
Wave Ventures
- Investor
Business Finland
- Partner
The European Union
- Partner
Aalto University
- Partner
DS SolidWorks
- Partner
CadWorks
- Partner
News
Contact us for more details!
Otakaari 5, Espoo, Finland
team (at) surgifymedical.com
Are you an investor, a physician or a patient? Would you like to hear more about Surgify? Don’t hesitate to contact us, let’s see what we can do together!